nandrolone has been researched along with Cardiomyopathies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chekodanova, NV; Chekunova, MP; Minkina, NA; Suvorov, IM; Zenkevich, ES | 1 |
| Davis, WM; Lin, TL; Long, SF | 1 |
| Dvornikov, VE; Kuliamin, VI; Segal', RG | 1 |
| Kutschera-Aichbergen, H | 1 |
4 other study(ies) available for nandrolone and Cardiomyopathies
| Article | Year |
|---|---|
[Pathogenetic therapy of cobalt-induced cardiomyopathies].
Topics: Adrenergic beta-Antagonists; Anabolic Agents; Animals; Cardiomyopathies; Cobalt; Drug Evaluation, Preclinical; Levodopa; Male; Nandrolone; Nandrolone Decanoate; Nialamide; Propranolol; Rats; Succinates; Sulfhydryl Compounds | 1980 |
Nandrolone decanoate reduces the premature mortality of cardiomyopathic hamsters.
Topics: Anabolic Agents; Animals; Body Weight; Cardiomyopathies; Cricetinae; Injections, Subcutaneous; Liver; Male; Mesocricetus; Myocardium; Nandrolone; Nandrolone Decanoate; Survival Rate | 1993 |
[Differential diagnosis and treatment of ischemic heart disease and dyshormonal myocardial dystrophy].
Topics: Adult; Cardiomyopathies; Coronary Disease; Decanoates; Diagnosis, Differential; Female; Heart; Humans; Middle Aged; Myotonic Dystrophy; Nandrolone; Ovarian Diseases | 1978 |
[Anabolic drugs in biochemical myocardial damages].
Topics: Aged; Anabolic Agents; Calcium; Cardiomyopathies; Electrocardiography; Female; Humans; Male; Middle Aged; Nandrolone | 1966 |